Aims To assess the occurrence of a histologically validated measure of transmural (TM) atrial ablation -pure R unipolar electrogram (UE) morphology change -at first-ablated left atrial posterior wall (LAPW) sites during contact force (CF)-guided pulmonary vein isolation (PVI). significantly greater impedance drop (median 13.5Ω versus 9.9Ω; p=0.003). Importantly, neither the first-site RF duration (14.9 versus 15.0s) nor the maximum ablation catheter tip distance moved (during RF) were significantly different, yet the mean CF was significantly higher at right-sided sites (16.5g versus 11.2g; p=0.002). Concurrent impedance and objectively annotated bipolar electrogram (BE) data demonstrated ~6-8Ω impedance drop and ~30% BE decrease at the time of first pure R UE morphology change.
Introduction
Radiofrequency (RF) catheter ablation for atrial fibrillation (AF) is a complex undertaking, since each lesion must be transmural (TM) and irreversible, yet without incurring excessive risk of extra-cardiac thermal trauma. Considerable research efforts have focussed on the identification of optimal targets for lesion creation during pulmonary vein isolation (PVI) and following the development of contact-force (CF) sensing catheters, recommendations for the CF "working range" and force time integral (FTI) were derived. 1, 2 However, the recent report of a 6-fold greater proportion of atrio-oesophageal fistula (AOF) cases associated with CFsensing catheter use compared to non-CF sensing catheters from a FDA MAUDE database analysis is concerning and suggests that these recommendations may be inappropriate. 3 It should be acknowledged that this entire evidence-base for target RF delivery during PVI was derived using subjective means of ablation catheter stability assessment. In TOCCATA (the first study reporting a relationship between CF and clinical outcome following PVI), valid ablation records for analysis were those "with stable CF for at least 15 consecutive seconds". 1 However, for this methodology to be appropriate two assumptions must be satisfied, neither validated in vivo: (1) CF "stability" (however that is defined) must equate with a certain "fixed" degree of catheter tip-tissue positional stability; (2) TM ablation during PVI must never be achieved within 15s. Therefore, these data should be considered provisional, pending further investigations following appropriate methodological advances.
From a theoretical perspective, greater understanding of the RF energy required to achieve TM lesions during PVI requires novel methodology to define a stable point of RF delivery within the human heart through entirely objective annotation processes, and accurate means to assess the TM nature of the tissue response to RF at any such site. Logically, one fundamental element of ablation catheter positional stability is constant (versus intermittent) 7 catheter-tissue contact. Adding complexity, both respiration and cardiac cycle-induced motion may create displacement at the catheter-tissue interface even in the setting of constant contact. While this may be accounted for using either respiratory or cardiac cycle RF annotation adjustment (i.e. no displacement assumed if the catheter returns to consecutive end-expiratory / end-diastolic sites within a pre-defined distance range), this may introduce error since RF delivery can only be proven to be "single site" when measures of cathetertissue interaction and tissue response to RF at sites without catheter displacement are defined, and shown to be present at sites demonstrating respiration or cardiac cycle-induced motion yet "adjusted" to a single site. Therefore, at least until any such "motion adjustment"
algorithms are proven to be accurate, avoidance of respiration / cardiac cycle adjustment should provide the most appropriate methodology underlying objective annotation of stable ablation catheter positions in vivo.
When considering the tissue response to RF application, electrogram changes indicating TM atrial ablation effects are well described in animal studies. Otomo et al identified that "pure R" unipolar electrogram (UE) morphology was 100% predictive of histologically proven TM lesions in porcine atria, and was catheter-tissue angle independent. 4 Using a contact-force 
VISITAG™ Module and CARTOREPLAY™ use
The VISITAG™ Module permits automated ablation site annotation through catheter CARTOREPLAY™ provides a means to retrospectively analyse electrogram data at all VISITAG™ Module annotated ablation sites, within 18 hours (data is deleted thereafter).
During this present report, UE morphological analysis was performed immediately following case completion, employing histologically validated reported criteria for TM RF effect (i.e. pure R morphology change). UE filtering was 0. Pre-ablation, all first-ablated LAPW annotated sites demonstrated RS UE morphology (e.g. figure 1A and data supplement). For sites adjacent to the left PV, ablation-induced pure R UE morphology was identifiably achieved in 21/23 cases (e.g. figure 1B and data supplement).
One case of inadvertent catheter displacement resulted in annotation termination at 4.43s
when RS UE morphology remained present (figure 5A, data supplement), while in another, gross artefact made UE morphology assessment impossible ( figure 15A , data supplement).
For annotated sites adjacent to the right PV, ablation-induced pure R UE morphology was achieved in all. However, one case of inadvertent catheter displacement at RF onset resulted 12 in 4.97s non-annotated RF delivery, so the time to pure R UE measurement was deemed invalid for analysis.
Annotated first-ablated LAPW site data is shown in The first 15s of annotated impedance and percentage bipolar electrogram decrease data is shown in figure 2 , with RF power below. At the times corresponding to the pure R UE morphology data in table 1, an impedance decrease of ~6-8Ω can be observed, accompanied by ~30% BE decrease for both left-sided and right-sided ablation sites. Notably, utilising this temperature-controlled RF protocol the delay to achieve 30W was ~6s. Correlation between the time to pure R UE morphology and the following factors was assessed: Total impedance drop; mean CF; maximum catheter tip distance moved; ablation catheter tip position SD; and BE amplitude (annotation start). The only significant correlation was in right-sided sites and with impedance drop -Spearman r -0.43 (-0.72 to -0.005; p=0.048).
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Conclusions
A key problem for any operator performing CF-guided PVI is successfully striking a balance between the competing risks of arrhythmia recurrence due to incomplete lesion formation 11 and extra-cardiac thermal trauma due to excessive local RF energy delivery. 3 Indeed, due to the close proximity of the oesophagus to the LAPW, inadvertent oesophageal thermal injury may be seen in up to 48% patients. 12 Worryingly, reports of an increase in the rate of atriooesophageal fistula following the introduction of CF-sensing catheters 3,13 indicates a likely causative relationship and highlights the risk of conducting PVI with an imperfect understanding of when TM ablation has been achieved.
The analyses described in this present report represent the first-in-man description of the LAPW "physiological response" to RF application at objectively annotated first-ablated sites meeting a suitable definition of a stable point of catheter tip-tissue contact in 3D space.
Specifically, we have shown that when an ablation catheter is maintained within a (SD) range of 2mm, acutely durable ablation effect was universally achieved following 15s temperaturecontrolled RF at 30W, with TM UE morphology change typically at <7s associated with a BE attenuation of ~30% and impedance drop of ~6-8Ω. Furthermore, we have identified superior catheter tip-tissue energy coupling for left-sided ablation sites, evidenced by significantly shorter time to pure R UE morphology, associated with a significantly greater total impedance drop. Finally, the absence of a significant correlation between the time to pure R UE morphology change and either the maximum catheter tip distance moved / tip position SD provides supportive evidence for the appropriateness of the 2mm SD positional stability filter "working range", without ACCURESP™ adjustment annotation protocol.
That these data are out of keeping with current views regarding what constitutes a "conventional / suitable" approach to RF application during PVI should come as no surprise 14 when considering the development of the current approach towards PVI and evidence available from other publications: (1) The original description of ~30s RF "per site", aiming for 80% BE attenuation was without scientific validation, 14 yet has remained unchallenged and perpetuated in methodology ever since; 6, 15 (2) This represents an important advance in RF ablation research methodology, since when the VISITAG™ Module is used as described in this present report, it comes as close as is presently possible to representing a "universal language" for the RF ablation "effector arm".
Consequently, and through the consistent application of CF and positional stability filters described here, future research protocols may be optimised, practice harmonised and with published outcomes then replicated by any operator able to maintain the catheter position and CF stability in the manner described.
The methodology presented here also represents a departure from studies utilising automated ablation site annotation yet failing to recognise the limitations of a CF filter permitting intermittent catheter-tissue contact (i.e. 30% minimum 5g) and the non-validated use of ACCURESP™ adjustment, 6 when considering a suitable definition for a stable point of RF application in vivo. Furthermore, an inherent additional problem with any system of ablation lesion delivery founded upon assessments of CF and energy delivery alone is clearly apparent when considering the differential ablative effect between left and right-sided sites demonstrated in this report. However, this should also not be surprising when recognising the recently reported range of the maximal impedance drop resulting from an ablation index (AI) value of 300; i.e. 0 to ~50Ω (see figure 3 , Das et al).
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Study limitations
All UE morphology data were collected retrospectively, so this report does not prove that modification of RF delivery based on real-time UE morphological assessment during VISITAG™ Module and CF-guided PVI is appropriate. However, this is worthy of further research, not least in view of the promising findings from a single-centre UE signal modification-based PVI study in humans, before the advent of CF-sensing and objective ablation site annotation. 20 Furthermore, neither oesophageal luminal temperature monitoring nor post-ablation endoscopic evaluation was employed; given the time to pure R UE morphology change of 3.1s demonstrated in figure 1 it is highly likely that some LAPW lesions were accompanied by inadvertent extra-cardiac thermal injury. Therefore, the approach to ablation described in this report is not a direct recommendation for others to follow without careful consideration. Rather, through adopting the methodology described in this present report there is now the opportunity for all to identify the most appropriate means to achieve TM ablation during PVI without excessive risks, using insights into one's "usual approach", through objective ablation site annotation.
The significantly greater time to pure R UE morphology at right-sided sites may in part have been due to increased LA wall thickness. Also, although the maximum distance of catheter tip motion did not differ between left and right-sided sites, there may have been a greater degree of LAPW motion beneath the catheter tip at right-sided sites, despite a significantly greater mean CF (i.e. out-of-phase, lateral motion). However, the significantly greater total impedance drop at left-sided sites remains the first demonstration of superior regional catheter tip-tissue energy coupling in vivo. Although this finding cannot be fully explained at present, these data may indicate that the more oblique catheter orientation routinely obtained during left-sided ablation may result in a greater surface area of ablation electrode in contact with the tissue, with even a relatively small difference potentially resulting in significantly greater power delivery. 21 Although the mechanisms underlying these observations await identification, this represents an important unknown variable in any attempt to harmonise RF ablation practice based upon ablation lesion quality markers incorporating CF, RF duration and power alone. 6 Maintaining a stable catheter position within the chosen 2mm SD range may require some novel operator "adjustments" for respiration-induced motion, particularly when the use of ACCURESP™ adjustment use during PVI remains non-validated. There is presently no means to describe any compensatory sheath / catheter movements utilised; jet ventilation may therefore improve the reproducibility of VISITAG™ Module and CF-guided PVI, but this requires further study. Finally, achieving durable PVI requires sufficient overlap between adjacent lesions; these present data provide no information concerning the diameter of TM ablative effects. However, through conducting similar investigations to those described here, the diameter of RF-induced thermal injury may be identified during PVI; these data have been collected and will be the subject of a future report.
Conclusions
Through appropriate use of the VISITAG™ Module and CARTOREPLAY™ during PVI, the TM nature of the tissue responses to RF may be investigated. These annotation tools provide a research foundation with greater scientific rigour, potentially better informing future RF ablation practice. 
